Spanish Red Biotech Pipeline
< Back
Drugs: National companies
Home
Toggle navigation
Pipeline
DRUGS: MULTINATIONAL SUBSIDIARIES
DRUGS: NATIONAL COMPANIES
RESEARCH PLATFORMS
DIAGNOSTICS AND PERSONALIZED MEDICINE
OTHER TECHNOLOGIES
Search
Charts
DRUGS: MULTINATIONAL SUBSIDIARIES
DRUGS: NATIONAL COMPANIES
DIAGNOSTICS AND PERSONALIZED MEDICINE
OTHER TECHNOLOGIES
Green pipeline
White pipeline
Spanish Red Biotech Pipeline
/
Pipeline
/
Drugs: National companies
Sylentis
SYL1801
Type:
Biodrugs/ Drugs
Therapeutic area:
Indication:
Macular degeneration
Phase:
2
Phase II
,
1
Phase I
,
2
Regulatory Preclinical
,
1
Non Regulatory Preclinical